BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Trivitron Acquires Ani Lab for $20.4 Million


11/27/2012 9:16:48 AM

Trivitron Healthcare today announced the 100% acquisition of Ani labsystem, a leader in the In Vitro Diagnostic space with its presence in Neonatal Screening and Cardiac Bio markers screening areas. Ani Labsystems is a group of companies consist of Ani Biotech, Ani Labsystems, Biopoint and K3. Trivitron is acquiring all these four group companies and the merger is known as Labsystems Diagnostics OY- A Trivitron Group Company. This global joint venture brings forth access to global manufacturing facility, a first of its kind for an Indian Medical Technology Company to go abroad for acquisition. While Neonatal Screening, Cardiac Biomarkers , Gastro and Respiratory diagnostics kits will continue to be manufactured in Finland, the Infectious Diseases and Women's health manufacturing will be shifted to The Trivitron Medical Technology Park based in Chennai, according to company's statement. With this acquisition, Trivitron has the capability to enter into Point of Care Diagnostics, Immuno Diagnostics and Molecular Diagnostics, the three of the fastest growing areas in the In Vitro Diagnostics field. Trivitron is already manufacturing Hematology and Clinical Chemistry kits from their Facilities. Hence this will make Trivitron a global In Vitro Diagnostic company with capability of manufacturing variety of Diagnostics Kits covering all major areas of In Vitro Diagnostics Field. In Chennai, Trivitron Healthcare has established South Asia’s first state-of-art medical technology manufacturing facility -The Trivitron Medical Technology Park and Trivitron’s innovation center at the IIT Madras.


 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->